Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy

Centre Hospitalier Universitaire de Saint Etienne

Status: Enrolling

Conditions: Bone Angioma

Treatments: Other: Collecting data from medical records

Study type: Observational

Funder types: Other

Identifiers

NCT06607731

IRBN312024/CHUSTE

Details and patient eligibility

About

The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age <18-years old and any association with neurological deficit.

Enrollment: 11 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.

Exclusion criteria

• Patients no treated by gelled alcohol sclerotherapy.

Trial design

11 participants in 1 patient group

Study population

Description:

Patients who have undergone percutaneous gel ethanol sclerosis for aggressive bone angioma at Saint-Etienne University Hospital.

Treatment:

Other: Collecting data from medical records